	销售和管理费用		日
Acadia Pharmaceuticals	USD 148.57M	12.22M	2026-06
Agios Pharmaceuticals	USD 38.46M	4.51M	2026-03
Alnylam Pharmaceuticals	USD 347.92M	65.41M	2026-06
BioCryst Pharmaceuticals	USD 95.78M	12.77M	2025-12
BioMarin Pharmaceutical	USD 258.28M	63.92M	2026-03
Immunic	USD 3.45M	451K	2025-12
Insmed	USD 247.26M	34.78M	2026-03
Ionis Pharmaceuticals	USD 130.07M	20.92M	2026-06
Karyopharm Therapeutics	USD 10.42M	861K	2026-03
Kyowa Hakko Kirin	JPY 43.74B	2.66B	2026-06
MacroGenics	USD 9.71M	1.77M	2026-03
Moderna	USD 216M	43M	2026-06
Neurocrine Biosciences	USD 383.1M	64.6M	2026-06
PTC Therapeutics	USD 73.89M	13.31M	2026-03
Puma Biotechnology	USD 16.82M	8.15M	2024-09
Regeneron Pharmaceuticals	USD 662.1M	14.4M	2026-06
Sarepta Therapeutics	USD 54.03M	51.35M	2026-03
Ultragenyx Pharmaceutical	USD 88M	1000K	2026-03
Vertex Pharmaceuticals	USD 582.2M	88.5M	2026-06